When a person suffers a serious hip fracture, surgeons must act quickly to stabilize the bone. During these surgeries, doctors sometimes use a medication called tranexamic acid (TXA) to help control bleeding and reduce the need for blood transfusions. This study looked at whether TXA actually made a difference for older patients undergoing surgery for broken hips.
Researchers tracked 283 patients over several months. They compared those who received the drug before surgery against those who received a placebo. The results showed that both groups had nearly identical rates of needing a transfusion, with about 81% of patients in both groups avoiding one. Other measures, like how long patients stayed in the hospital or their risk of being readmitted within 30 days, also showed no significant difference between the two groups.
While the drug did not show a benefit for reducing transfusions, the study did find that the type of surgery performed played a much larger role. Patients undergoing one specific type of surgery had higher transfusion rates than those getting another. Because the trial was stopped early due to lack of evidence that the drug worked, it suggests that the surgical method itself may be more important than the use of tranexamic acid in these cases.
